Patrick Soon-Shiong accused of more conflicts of interest; Eli Lilly expands in San Diego
→ NantCell founder and recent appointee to the U.S. Department of Health and Human Services Health IT Advisory Committee Patrick Soon-Shiong is embroiled in yet another legal battle asserting conflicts of interest in his business dealings. This time, the suit claims he and two colleagues are low-balling shareholders by attempting to purchase a startup, Altor, at $19 million less than its most recent valuation, taking advantage of their positions on the board of the startup. Previous reports in STAT and Politico have drawn attention to other conflicts of interest in his business and non-profit work.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.